Flemming Bendtsen
#158,855
Most Influential Person Now
Flemming Bendtsen's AcademicInfluence.com Rankings
Flemming Bendtsenphilosophy Degrees
Philosophy
#9075
World Rank
#12577
Historical Rank
Logic
#6071
World Rank
#7552
Historical Rank

Download Badge
Philosophy
Flemming Bendtsen's Degrees
- PhD Biomedical Sciences University of Copenhagen
- Doctorate Medicine University of Copenhagen
Why Is Flemming Bendtsen Influential?
(Suggest an Edit or Addition)Flemming Bendtsen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. (2015) (1958)
- Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database (2006) (543)
- Long term prognosis of fatty liver: risk of chronic liver disease and death (2004) (492)
- Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. (2004) (404)
- Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial (2008) (301)
- Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites (2009) (297)
- Serum YKL-40 is increased in patients with hepatic fibrosis. (2000) (261)
- Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease (2003) (219)
- Reduced central blood volume in cirrhosis. (1989) (197)
- Cirrhotic cardiomyopathy: pathogenesis and clinical relevance (2014) (193)
- Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. (1985) (186)
- Final results of a long-term, clinical follow-up in fatty liver patients (2009) (184)
- Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. (2016) (182)
- Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. (1986) (171)
- Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. (2014) (161)
- Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy (2014) (159)
- The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120). (2020) (146)
- Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality. (2008) (142)
- The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis (2016) (138)
- Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. (2000) (128)
- Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. (2004) (124)
- Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. (1995) (123)
- Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome (2007) (119)
- Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? (1997) (117)
- Progression From Acute to Chronic Pancreatitis: Prognostic Factors, Mortality, and Natural Course (2011) (112)
- Lactate metabolism in chronic liver disease (2013) (111)
- Dyssynchronous electrical and mechanical systole in patients with cirrhosis. (2002) (109)
- Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal (1999) (105)
- The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis (2018) (104)
- Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding (1990) (101)
- Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis (2011) (95)
- New insights into cirrhotic cardiomyopathy. (2013) (95)
- eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in Crohn's disease (2012) (93)
- 379 Characteristics and Long-Term Prognosis of Lean Patients With Nonalcoholic Fatty Liver Disease (2014) (93)
- Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. (1991) (92)
- Metabolic and inflammatory faecal markers in collagenous colitis (2007) (91)
- BNP and N‐terminal proBNP are both extracted in the normal kidney (2006) (90)
- Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. (1994) (88)
- Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. (2001) (76)
- Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems. (2007) (72)
- The Effect of Anti-Tumor Necrosis Factor Alpha Agents on Postoperative Anastomotic Complications in Crohn’s Disease: a Systematic Review (2013) (70)
- Estimated central blood volume in cirrhosis: Relationship to sympathetic nervous activity, β‐adrenergic blockade and atrial natriuretic factor (1992) (70)
- Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. (2003) (70)
- Cardiac and proinflammatory markers predict prognosis in cirrhosis (2014) (69)
- Infliximab and complications after colectomy in patients with ulcerative colitis. (2012) (67)
- Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis (2010) (66)
- Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers (2016) (65)
- Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects. (2014) (65)
- Pharmacological approach to acute pancreatitis. (2008) (65)
- Arterial compliance in patients with cirrhosis: stroke volume-pulse pressure ratio as simplified index. (2001) (64)
- Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis (2017) (64)
- Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis (2019) (63)
- Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study. (2014) (62)
- Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis (2003) (60)
- Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis. (2005) (59)
- Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury (2002) (59)
- Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial (2017) (58)
- Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis. (2001) (57)
- Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender. (2003) (57)
- Danish patients with chronic pancreatitis have a four-fold higher mortality rate than the Danish population. (2010) (55)
- Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery. (2016) (54)
- Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome (2008) (54)
- The risk of fractures among patients with cirrhosis or chronic pancreatitis. (2014) (53)
- The cardiorenal link in advanced cirrhosis. (2012) (53)
- Circulating atrial natriuretic peptide (ANP) and central blood volume (CBV) in cirrhosis. (2008) (53)
- Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis. (2001) (52)
- Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes. (2007) (51)
- Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects. (2008) (51)
- Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. (1988) (50)
- Vasoactive substances in the circulatory dysfunction of cirrhosis (2001) (50)
- Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial (2018) (49)
- Increased arterial compliance in decompensated cirrhosis. (1999) (48)
- Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials. (2014) (47)
- Propranolol and haemodynamic response in cirrhosis. (1991) (47)
- Cardiac dysfunction in cirrhosis – does adrenal function play a role? A hypothesis (2012) (47)
- Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes (2014) (46)
- Plasma cystatin C as a marker of renal function in patients with liver cirrhosis (2002) (45)
- Pathogenetic background for treatment of ascites and hepatorenal syndrome (2008) (45)
- Carvedilol or propranolol in portal hypertension? A randomized comparison (2012) (44)
- Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects (2005) (44)
- Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals. (2011) (44)
- Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation (2020) (43)
- High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis (2012) (42)
- Review article: volume expansion in patients with cirrhosis (2002) (42)
- Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort (2018) (40)
- Oesophageal pressure–cross‐sectional area distributions and secondary peristalsis in relation to subclassification of systemic sclerosis (2001) (40)
- Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic study. (1997) (39)
- Cirrhotic Multiorgan Syndrome (2015) (39)
- Effect of terlipressin on blood volume distribution in patients with cirrhosis (2004) (39)
- Ascites: Pathogenesis and therapeutic principles (2009) (39)
- Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics (2006) (39)
- Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. (2018) (38)
- Bile acids and cardiovascular function in cirrhosis (2017) (38)
- Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity of liver disease and splanchnic haemodynamics. (1990) (38)
- Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C. (2003) (37)
- Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis (2015) (37)
- Cardiodynamic state is associated with systemic inflammation and fatal acute‐on‐chronic liver failure (2020) (37)
- Management of cirrhotic ascites (2015) (37)
- Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case‐cohort study (2017) (36)
- Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension (2009) (36)
- Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis (2018) (36)
- Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis. (1992) (35)
- Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study (2021) (35)
- Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature (2015) (33)
- Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort (2017) (33)
- Effects of tilting on central hemodynamics and homeostatic mechanisms in cirrhosis (2004) (33)
- Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume (2006) (32)
- Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis. (1996) (32)
- Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial (2003) (31)
- Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis. (2018) (31)
- Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. (2000) (31)
- The recent reduction in mortality from bleeding oesophageal varices is primarily observed from Days 1 to 5 (2010) (31)
- Effects of a long‐acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: A randomized, double‐blind, controlled trial (2001) (31)
- Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis (2013) (30)
- PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension (2014) (30)
- A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort. (2019) (30)
- Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005. (2008) (29)
- Duodenal bulb acidity in patients with duodenal ulcer. (1987) (29)
- The pharmacokinetics of octreotide in cirrhosis and in healthy man. (1997) (29)
- Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome (2005) (28)
- Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow Up in a Danish Population-Based Inception Cohort. (2019) (28)
- New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory state (2014) (27)
- Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis (1991) (27)
- Histological characteristics and prognosis in patients with fatty liver (2005) (27)
- Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study (2014) (26)
- Pathophysiological aspects of pulmonary complications of cirrhosis (2007) (26)
- Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis. (1987) (26)
- Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients. (2016) (25)
- Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis (1990) (25)
- Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population. (2010) (25)
- An update on cirrhotic cardiomyopathy (2019) (25)
- [785] RECOMBINANT FACTOR VIIA (RFVIIA) FOR ACTIVE VARICEAL BLEEDING IN PATIENTS WITH ADVANCED CIRRHOSIS: A MULTI-CENTRE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (2007) (25)
- Q‐T interval (QTC) in patients with cirrhosis: relation to vasoactive peptides and heart rate (2007) (25)
- Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis (2016) (25)
- TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes (2014) (24)
- Indications for portal pressure measurement in chronic liver disease (2012) (23)
- Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome (2018) (23)
- Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices. (1991) (23)
- Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis. (2017) (22)
- Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs. (1999) (22)
- Betablockers induce cardiac chronotropic incompetence. (2012) (22)
- Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers (2014) (22)
- Complications of cirrhosis. A 50 years flashback (2015) (21)
- Hyponatraemia during terlipressin therapy (2010) (21)
- Association of markers of bacterial translocation with immune activation in decompensated cirrhosis (2014) (20)
- No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion (2013) (19)
- A phylogenetic analysis elucidating a case of patient-to-patient transmission of hepatitis C virus during surgery. (2000) (19)
- Cardiac sympathetic imaging with mIBG in cirrhosis and portal hypertension: relation to autonomic and cardiac function. (2012) (19)
- Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease (2018) (19)
- Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study. (2014) (19)
- Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies (2021) (19)
- Pancreatic insufficiency. Duodenal and jejunal pH, bile acid activity, and micellar lipid solubilization. (1990) (19)
- Anti-NKG2D mAb: A New Treatment for Crohn’s Disease? (2017) (18)
- Fecal microbiota transplantation in hepatic encephalopathy: a systematic review (2021) (18)
- Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis (2019) (18)
- Cardiac output determined by echocardiography in patients with cirrhosis: comparison with the indicator dilution technique (2003) (18)
- Factors associated with long-term mortality in acute pancreatitis (2011) (18)
- [Pediatric colonoscopy]. (1998) (18)
- Hepatic venous oxygen content in alcoholic cirrhosis and non-cirrhotic alcoholic liver disease. (2008) (17)
- Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis (2020) (17)
- Acid–base disturbance in patients with cirrhosis: relation to hemodynamic dysfunction (2015) (17)
- Endoscopic Doppler ultrasound for measurement of azygos blood flow. Validation against thermodilution and assessment of pharmacological effects of terlipressin in portal hypertension. (2001) (17)
- Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn’s Disease: Reflects Inflammation and Drug Effects (2016) (17)
- Low Risk of Unemployment, Sick Leave, and Work Disability Among Patients with Inflammatory Bowel Disease: A 7-year Follow-up Study of a Danish Inception Cohort (2015) (17)
- The aetiology of acute and chronic pancreatitis over time in a hospital in Copenhagen. (2010) (17)
- Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study (2014) (16)
- Increased circulating calcitonin in cirrhosis. Relation to severity of disease and calcitonin gene-related peptide. (2000) (16)
- The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis (2018) (16)
- Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects (2016) (15)
- The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patients (2012) (15)
- Profermin is Efficacious in Patients with Active Ulcerative Colitis—A Randomized Controlled Trial (2013) (15)
- The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis. (2001) (15)
- Does cardiac dysfunction explain deleterious effects of beta‐blockers in cirrhosis and refractory ascites? (2011) (15)
- Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation (2021) (15)
- Safety and efficacy of Profermin® to induce remission in ulcerative colitis. (2012) (15)
- Serum levels of short‐chain fatty acids in cirrhosis and hepatic coma (1991) (15)
- Cardiac dysfunction in cirrhosis: a 2-year longitudinal follow-up study using advanced cardiac imaging. (2019) (14)
- [Cimetidine therapy in radio-negative dyspepsia]. (1983) (14)
- Additional antacid does not increase the effect of cimetidine in gastric ulcer disease. (1984) (14)
- Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort (2019) (13)
- Impaired free water excretion in child C cirrhosis and ascites: relations to distal tubular function and the vasopressin system (2010) (13)
- Adherence to guidelines in bleeding oesophageal varices and effects on outcome: comparison between a specialized unit and a community hospital (2010) (13)
- Bacteriaemia after injection sclerotherapy of oesophageal varices. (2008) (13)
- Hepatic-intestinal disposal of endogenous human alpha atrial natriuretic factor99-126 in patients with cirrhosis. (1990) (13)
- NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration. (2017) (13)
- Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature (2009) (12)
- Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis. (2001) (12)
- Few complications after paracentesis in patients with cirrhosis and refractory ascites. (2011) (12)
- Increased Arterial Compliance in Cirrhosis is Related to Decreased Arterial C-type Natriuretic Peptide, but not to Atrial Natriuretic Peptide (2003) (11)
- Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases. (2020) (11)
- The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation (2017) (11)
- Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy (2020) (11)
- Transit-time analysis in hepatic cir rhosis (1999) (11)
- Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension (2015) (11)
- Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease - a Danish population-based inception cohort with 10 years of follow-up. (2020) (10)
- Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial (2020) (9)
- Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosis (2017) (9)
- Hyponatremia in patients treated with terlipressin: Mechanisms and implications for clinical practice (2011) (9)
- Prevalence and Risk Factors of Moderate to Severe Hepatic Steatosis in HIV Infection: The Copenhagen Co-Morbidity Liver Study. (2020) (9)
- Gastric potential difference and pH in ulcer patients and normal volunteers during Stroop's colour word conflict test. (1989) (9)
- Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease (2020) (9)
- Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia. (2010) (9)
- Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol. (1989) (9)
- Detection of early central circulatory transits in patients with cirrhosis by gamma variate fit of indicator dilution profiles. (2005) (9)
- Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis (2021) (8)
- Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction (2014) (8)
- Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival? (2018) (8)
- Acetaminophen toxicity induces mitochondrial complex I inhibition in human liver tissue (2020) (8)
- Prognosis in patients with cirrhosis and mild portal hypertension (2006) (8)
- Treatment of ascites and spontaneous bacterial peritonitis - part I. (2012) (8)
- Splanchnic removal of human alpha-atrial natriuretic peptide in humans: enhancement after food intake. (1990) (8)
- Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study (2016) (8)
- Total plasma clearance versus urinary plasma clearance of 51Cr-EDTA in patients with cirrhosis with and without fluid retention (2015) (7)
- Arterial pressure profile in patients with cirrhosis: Fourier analysis of arterial pulse in relation to pressure level, stroke volume, and severity of disease: On the reduction of afterload in the hyperdynamic syndrome (2012) (7)
- Predictive value of indocyanine green retention test and indocyanine green clearance in Child‐Pugh class A patients (2015) (7)
- Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension (2011) (7)
- Normal red cell cardiac output in the hyperkinetic syndrome of alcoholic cirrhosis. (2001) (7)
- Intraduodenal pH During Omeprazole Treatment in Duodenal Ulcer Patients (1986) (7)
- 755 CARDIAC FUNCTION STUDIED BY DOBUTAMIN STRESS MRI IN PATIENTS WITH MILD CIRRHOSIS (2009) (7)
- Increased prevalence of liver fibrosis in people living with HIV without viral hepatitis compared to population controls. (2020) (6)
- High Abundance of Proteobacteria in Ileo-Anal Pouch Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation (2020) (6)
- No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial (2018) (6)
- Effects of Transjugular Intrahepatic Portosystemic Shunt (Tips) on Blood Volume Distribution in Patients with Cirrhosis (2016) (6)
- 99mTc‐labelled human serum albumin cannot replace 125I‐labelled human serum albumin to determine plasma volume in patients with liver disease (2013) (6)
- Effects of a single dose of terlipressin on transcutaneous oxygen pressures (2010) (6)
- Assessment of central blook volume in cirrhosis by radionusclide angiography: What does it really mean? (1994) (6)
- [234] CARDIAC EFFECTS OF TERLIPRESSIN IN CIRRHOSI S. UNMASKING A CIRRHOTIC CARDIOMYOPATHY? (2007) (6)
- Left atrial volume changes assessed by real time 3-dimensional echocardiography in relation to liver function and prognosis in patients with cirrhosis (2020) (6)
- Plasma ADAMTS-13 protein is not associated with portal hypertension or hemodynamic changes in patients with cirrhosis. (2016) (6)
- Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases (2021) (6)
- S1363 Risk Factors for Progression From Acute to Chronic Pancreatitis (2010) (6)
- Plasma volume changes during hypoglycaemia: the effect of arterial blood sampling. (1990) (6)
- Long-Term, Clinical Follow-Up in Fatty Liver Patients (2011) (6)
- Terlipressin vs. Octreotide in Bleeding Esophageal Varices (2009) (6)
- Hepatic steatosis associated with exposure to elvitegravir and raltegravir. (2021) (6)
- Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade. (1993) (5)
- The royal free hospital cirrhosis glomerular filtration rate: Validation in a danish cohort (2017) (5)
- Rifaximin for people with hepatic encephalopathy (2015) (5)
- Neutrophil gelatinase‐associated lipocalin and cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction (2017) (5)
- Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: It takes three to tango. (2018) (5)
- Using MR elastography to assess portal hypertension and response to beta‐blockers in patients with cirrhosis (2021) (5)
- Endoscopic ultrasound duplex scanning for measurement of portal venous flow. Validation against transit time ultrasound flowmetry in pigs. (1999) (5)
- Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention (2011) (5)
- Effect of omeprazole on intragastric and duodenal bulb acidity in duodenal ulcer patients (1989) (5)
- Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis. (2022) (5)
- Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomised controlled trial. (2019) (5)
- Volume expansion in patients with cirrhosis (2002) (5)
- Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis (2018) (5)
- Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers. (1999) (4)
- [Cirrhotic cardiomyopathy: prolonged QTc-interval and dyssynchronic electrical and mechanical systole in cirrhosis]. (2004) (4)
- Ehealth: Impact of Web-Based Treatment Optimization Solution (Traffic Light) on the Quality of Life in Crohn's Disease Patients Treated With Infliximab (2011) (4)
- The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial (2022) (4)
- Pathophysiological-based treatments of complications of cirrhosis (2020) (4)
- Cardiac Biomarkers in Cirrhosis and Portal Hypertension: Relation to Circulatory and Cardiac Dysfunction (2015) (4)
- Effect of meal and propranolol on whole body and splanchnic oxygen consumption in patients with cirrhosis. (2006) (4)
- Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study (2022) (4)
- Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration (2022) (4)
- Acyclovir in the prevention of duodenal ulcer recurrence. (1990) (4)
- Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis. (2022) (3)
- Assessment of central blood volume in cirrhosis by radionuclide angiography (1994) (3)
- 295 LOW CARDIAC INDEX PREDICTS SURVIVAL AND RENAL FAILURE IN PATIENTS WITH ASCITES. EVIDENCE OF A HEART-KIDNEY AXIS IN CIRRHOSIS (2008) (3)
- Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease (2021) (3)
- Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis (2022) (3)
- The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis. (2021) (3)
- Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn’s disease – a real-world two-center cohort study (2021) (3)
- Advances in the treatment of portal hypertension in cirrhosis (2016) (3)
- Effects of octreotide on serum insulin-like growth factor I and insulin-like growth factor binding proteins in patients with cirrhosis (2002) (3)
- NAFLD: Cardiovascular complications of NAFLD—they do matter (2015) (3)
- [Effect of N-acetylcysteine on prothrombin index in patients with uncomplicated paracetamol poisoning]. (2004) (3)
- Low incidence of non-alcoholic steatohepatitis in a Danish liver unit. (2012) (3)
- Poor concordance between liver stiffness and non-invasive fibrosis scores in HIV infection without viral hepatitis. (2020) (3)
- [The histological picture of the gastric and duodenal mucosa in X-ray negative dyspepsia. Before and after treatment with cimetidine]. (1984) (3)
- [Cirrhosis of the liver]. (2014) (3)
- Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily (1990) (3)
- Fourier analysis of arterial pulse in patients with advanced cirrhosis indicates reduced wave reflections that may protect against manifest cardiac dysfunction (2011) (3)
- Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries? (2009) (3)
- Bleeding oesophageal varices. (1996) (3)
- [Liver biopsy in liver patients with coagulopathy]. (2008) (3)
- Carvedilol versus non‐selective beta‐blockers for portal hypertension in cirrhosis (2015) (3)
- Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death (2016) (3)
- Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study (2020) (3)
- There is room for diminished central and arterial blood volume in cirrhosis (1991) (3)
- Aquaporin‐2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality (2017) (3)
- Effects of treatment with &bgr;-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosis (2011) (3)
- Gamma‐variate plasma clearance versus urinary plasma clearance of 51Cr‐EDTA in patients with cirrhosis with and without fluid retention (2017) (2)
- Central blood volume in cirrhosis (1993) (2)
- [Hepatorenal syndrome: diagnosis, treatment and prevention]. (2013) (2)
- [Cocaine-triggered ischaemic enteritis]. (2009) (2)
- Integrative genomic profiling of hepatocellular adeno- mas identify mutational processes involved in malignant transformation (2013) (2)
- P813 Occurrence, disease course and prognosis of perianal Crohn’s disease in a Danish population-based inception cohort—a 10-year follow-up study (2018) (2)
- Variceal Rebleeding: Drugs, Endoscopy or Both (2014) (2)
- [Esophago-gastro-duodenoscopy of pediatric patients]. (1997) (2)
- A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019 (2021) (2)
- [Prediction of bleeding risks and death in cirrhosis based on hemodynamic and metabolic variables. A study of patients with esophageal varices without previous bleeding]. (1995) (2)
- [Increased survival following antibiotic prophylaxis in patients with cirrhosis and upper gastrointestinal hemorrhage]. (2005) (2)
- Pharmacological effects are model specific in animal models of portal hypertension (2008) (2)
- Oesophageal varices prior to bleeding. Diagnosis and physiological and therapeutic effects of propranolol in cirrhosis. (1993) (2)
- DOP041 Surgery and hospitalisation in patients with inflammatory bowel disease; 10-year follow-up of a Danish population-based inception cohort (2018) (1)
- Editorial: the role of statins in the treatment of alcohol‐related cirrhosis – Authors’ reply (2017) (1)
- Effect on splanchnic and systemic haemodynamics of a liquid meal alone and in combination with propranolol in patients with cirrhosis (1991) (1)
- P1337 : Randomized trial with rifaximin in liver cirrhosis. Effects on the haemodynamic and inflammatory state (2015) (1)
- Transjugular intrahepatic portosystemic shunt: impact on systemic haemodynamics and renal and cardiac function in patients with cirrhosis (2017) (1)
- The use of proton pump inhibitors among patients with alcoholic cirrhosis is not related with increased risk of death (2018) (1)
- P613 Surgery rates in Danish incident cases of ulcerative colitis and Crohn's disease in the era of biological treatment – a seven-year cohort study follow up (2013) (1)
- Association of low mechano‐energetic efficiency and prognosis in liver cirrhosis (2022) (1)
- Reply: To PMID 24389306. (2014) (1)
- 527 IMBALANCES IN PROINFLAMMATORY CYTOKINES ARE ASSOCIATED WITH PULMONARY DYSFUNCTION AND HEPATOPULMONARY SYNDROME IN CIRRHOSIS (2010) (1)
- Outcomes of COVID-19 among Patients with Chronic Liver Disease: A Danish Prospective, Population-Based Cohort Study (2022) (1)
- In Crohn’s Disease, an Aggressive Disease Course is Related to an Increased Abundancy of Proteobacteria; A Seven Year Follow Up Study (2017) (1)
- [Patients with decompensated cirrhosis should be offered rehabilitation at discharge]. (2013) (1)
- Letter: safety and efficacy of using statins in patients with cirrhosis—authors' reply (2017) (1)
- Pathophysiology Behind Cardiopulmonary Complications of Cirrhosis and Portal Hypertension (2020) (1)
- Deep Learning Surpasses Gastrointestinal Experts at Classifying Endoscopic Severity in Patients with Ulcerative Colitis (2021) (1)
- Electro-mechanical dissociation in the heart in patients with cirrhosis (2001) (1)
- Postprandial Increase in Mesenteric Blood Flow is Attenuated in Parkinson’s Disease: A Dynamic PC-MRI Study (2021) (1)
- [Treatment of esophageal varices]. (2001) (1)
- Gastric Emptying Is Not Delayed and Does Not Correlate With Attenuated Postprandial Blood Flow Increase in Medicated Patients With Early Parkinson's Disease (2022) (1)
- Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II. (2012) (1)
- DOP82 Direct and indirect costs of inflammatory bowel disease in the biological era; 10 years of follow-up in a Danish population-based inception cohort (2019) (1)
- Cardiac fibrosis and coronary atherosclerosis in cirrhosis. Indications of cirrhotic cardiomyopathy (2018) (1)
- 205 RELATION BETWEEN BAROREFLEX SENSITIVITY AND PULMONARY DYSFUNCTION IN CIRRHOSIS: EFFECT OF HYPEROXIA (2009) (1)
- The role of bile acids in the development of structural myocardial changes and cardiac dysfunction in patients with cirrhosis (2018) (1)
- Azygos and hepatic extraction of atrial natriuretic factor (ANF) in patients with cirrhosis. No evidence of reduced disposal. (1993) (1)
- Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis (2019) (1)
- Determination of hepatic clearance by derivations of the indocyanine green retention test in cirrhosis (2022) (1)
- 169 CARVEDILOL OR PROPRANOLOL IN PORTAL HYPERTENSION? A RANDOMIZED CLINICAL TRIAL (2010) (1)
- [Treatment of bleeding from oesophageal varices in patients with cirrhosis]. (2007) (1)
- [The hepatorenal syndrome. From physiopathology to clinical practice]. (2004) (1)
- High Accuracy in Classifying Endoscopic Severity in Ulcerative Colitis Using Convolutional Neural Network (2022) (1)
- The PHES Score Does Not Correlate With Blood Ammonia Levels, Circulating Endotoxins or Markers of Systemic Inflammation (2017) (0)
- [Intestinal lympho-nodular hyperplasia associated with hypogammaglobulinemia]. (1981) (0)
- Su1080 Increased Risk of Work Disability in Inflammatory Bowel Disease Patients After Seven Years of Follow-Up - A Population-Based Cohort Study (2015) (0)
- Long-time effects of a slow release somatostatin analogue (Lanreotide SR) on hepatic venous pressure gradient in patients with proven esophageal varices (2003) (0)
- P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases (2021) (0)
- Pancreatic insufficiency (2020) (0)
- Collagen type IV remodeling gender-specifically predicts mortality in decompensated liver cirrhosis (2019) (0)
- Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity? (2022) (0)
- 733 NEOEPITOPES DERIVED FROM EXTRACELLULAR MATRIX DEGRADATION REFLECT LIVER FUNCTION, FIBROSIS AND HVPG IN HIV-PATIENTS (2013) (0)
- Systemic inflammation is associated with cardiodynamic state in acute-on-chronic liver failure (2020) (0)
- DOP43 Impact of Inflammatory Bowel Diseases on the phenotype and severity of psoriasis and spondyloarthropathies (2021) (0)
- Nurse assisted follow-up after admission with decompensation in cirrhosis: a systematic review and meta-analysis (2020) (0)
- 294 CRITICAL ISCHAEMIA IN PERIPHERAL LIMBS DURING TERLIPRESSIN TREATMENT (2008) (0)
- SAT-027-Effects of propranolol on liver- and spleen-stiffness measured by MR-Elastography in patients with cirrhosis (2019) (0)
- FRI-130-Changes in the extracellular matrix of the heart and the liver assessed by MRI with T1-mapping are closely linked in cirrhosis: Is inflammation the shared pathway? (2019) (0)
- M1383 Mortality and Prognostic Factors in Chronic Pancreatitis - A Long-Term Follow-up Study of a Danish Cohort (2010) (0)
- Session 8: Providing Scientific Evidence: RCTs and Beyond (2007) (0)
- Different inflammasome activation predisposes for acute-on-chronic liver failure depending on hepatic compensation in human and experimental liver cirrhosis (2020) (0)
- [Violence against women in their partnerships. III. Education, employment and housing]. (1985) (0)
- Tu1171 Reduced Recurrence Rates in Crohn's Disease but Not in Ulcerative Colitis in the Era of Immunomodulators and Biological Therapy: A 7-Year Population-Based Follow-Up Study of Inflammatory Bowel Disease (2014) (0)
- Subject Index Vol. 28, 2010 (2011) (0)
- OP07 Artificial intelligence surpasses gastrointestinal experts in the classification of endoscopic severity among Ulcerative Colitis (2021) (0)
- 585 CARDIAC ADRENERGIC FUNCTION ASSESSED BY I-METAIODOBENZYL/GUANIDINE MYOCARDIAL SCINTIGRAPHY IN PATIENTS WITH CIRRHOSIS (2012) (0)
- Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604. (2009) (0)
- Contents Vol. 28, 2010 (2011) (0)
- [Acute pulmonary failure in acetylsalicylic acid poisoning]. (1987) (0)
- The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010–2020 (2022) (0)
- [Ranitidine versus cimetidine in duodenal ulcer. Pharmcokinetic and pharmacodynamic studies]. (1983) (0)
- [Old wine in new bottles: Lactulose works in hepatic encephalopathy]. (2016) (0)
- Cardiovascular Effects of a Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis (2017) (0)
- P703 Risk of disease progression in patients with Crohn's disease after 7 years of follow-up in a Danish population-based inception cohort. (2017) (0)
- [Violence to women in their partnerships. I. Occurrence, mechanisms of injury, types of injury and treatment]. (1985) (0)
- [Terlipressin acetate]. (2022) (0)
- Central blood volume in cirrhosis: Relationship to sympathetic nervous activity and atrial natriuretic factor (ANF) (1991) (0)
- Distribution of blood volumes in cirrhosis. Relation to gender and antropometrics (2003) (0)
- Sa1047 Increased Hepatic Iron Deposition and Long-Term Prognosis of Patients With Nonalcoholic Fatty Liver Disease (2014) (0)
- P743 Bone mineral disease is insufficiently evaluated in patients with inflammatory bowel disease at risk of metabolic bone disease: results from a Danish population-based inception cohort study (2019) (0)
- P939 NGAL IN PATIENTS WITH LIVER CIRRHOSIS: RELATION TO PATIENT CHARACTERISTICS AND KINETICS (2014) (0)
- P634 Predictors of response and course in patients with inflammatory bowel disease treated with biological therapy: The Danish IBD-Biobank project (2020) (0)
- SAT-055-Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial (2019) (0)
- MRI-derived myocardial extracellular volume is closely associated with markers of collagen formation in cirrhosis (2020) (0)
- Acknowledgement to our reviewers (2006) (0)
- P597 Reduced recurrence rates in Crohn's disease in the era of biological therapy: A 7-year population-based follow-up study of inflammatory bowel disease (2014) (0)
- P127 Environmental Factors in an Inception Cohort of IBD Patients With a Steep Increase of Incidence From 2003–2005 in Copenhagen County and City: A DCCD Study (2007) (0)
- [Alcohol-related liver cirrhosis and related complications]. (2021) (0)
- Effect of beta-adrenergic blockade on elevated arterial and low systemic vascular resistance compliance in cirrhosis (2001) (0)
- [Ranitidine (Zantac). A new H2 receptor antagonist]. (1983) (0)
- Gluco-regulatory disturbances in primary biliary cholangitis and non-alcoholic fatty liver disease compared with healthy individuals (2022) (0)
- Systemic inflammation is associated with hyperdynamic circulation and predicts acute-on-chronic liver failure (2020) (0)
- [Portal pressure should be measured on suspicion of portal hypertension]. (2010) (0)
- Evidence of a vasopressin-independent AQP2 expression and water retention in patients with Child C cirrhosis and ascites (2008) (0)
- P786 The use and escalation of treatments in patients with inflammatory bowel disease; a 10 years follow-up of a Danish population-based inception cohort (2018) (0)
- Statins for cirrhosis: almost ready for clinical application (2020) (0)
- Machine learning models for prediction of severe portal hypertension in patients with compensated cirrhosis (2022) (0)
- A Note of Thanks to Referees (1997) (0)
- [Violence to women in their partnerships. II. Demographic conditions (age, marital status and children)]. (1985) (0)
- The risk of fractures in cirrhosis and chronic pancreatitis. a danish nationwide retrospective matched cohort study (2013) (0)
- Propranolol reduces the meal-induced increase in oxygen consumption in patients with cirrhosis (2002) (0)
- 176 EFFECTS OF TREATMENT WITH BETA-BLOCKER AND ALDOSTERONE ANTAGONIST ON CENTRAL AND PERIPHERAL HAEMODYNAMICS AND OXYGENATION IN CIRRHOSIS (2011) (0)
- function portal hypertension : relation to autonomic and cardiac IBG in cirrhosis and m Cardiac sympathetic imaging with (2014) (0)
- [Magnetic resonance imaging for the diagnosis of non-alcoholic fatty liver disease]. (2019) (0)
- 710 TIMP-1 IN PATIENTS WITH CIRRHOSIS: RELATION TO LIVER DYSFUNCTION, PORTAL HYPERTENSION, AND HAEMODYNAMIC CHANGES (2013) (0)
- P940 IS CYSTATIN C (CYSTC) AN IDEAL MARKER OF RENAL DYSFUNCTION IN CIRRHOSIS (2014) (0)
- 584 NEW VASCULAR BIOMARKERS IN CIRRHOSIS: ORGAN EXTRACTION AND RELATION TO THE VASODILATORY STATE (2013) (0)
- Terlipressin vs. Octreotide in Bleeding Esophageal Varices. Authors' reply (2009) (0)
- Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study (2020) (0)
- 247 HIGH LEVELS OF SOLUBLE TNF-ALPHA-RECEPTOR-I ARE ASSOCIATED WITH POOR OUTCOME IN CIRRHOSIS WITH PORTAL HYPERTENSION (2013) (0)
- The Intestinal Dysbiosis Found in IBD-Patients are Linked to Colonization with Extra-Intestinal Pathogenic Escherichia Coli (2017) (0)
- Normal red blood cell cardiac output in hyperkinetic syndrome of alcoholic cirrhosis (2001) (0)
- The composition of the bile acid pool is closely associated with fibrosis in the heart and liver of patients with cirrhosis (2022) (0)
- Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review (2023) (0)
- 636 EFFECTS OF ALPHA- AND BETA-ADRENERGIC BLOCKADE ON CIRCULATORY REGULATION AND OXYGENATION IN CIRRHOSIS (2012) (0)
- Demographic , clinical , and biochemical characteristics of 22 patients with cirrhosis and ascites (2008) (0)
- 193 DETERMINANTS OF THE HYPERDYNAMIC CIRCULATION AND CENTRAL HYPOVOLAEMIA IN CIRRHOSIS AND PORTAL HYPERTENSION (2009) (0)
- 591 BACTERIAL DNA MEASUREMENTS IN PATIENTS WITH CIRRHOSIS UNDERGOING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) INSERTION (2013) (0)
- S1961 Critical Ischaemia in Peripheral Limbs During Terlipressin Treatment (2008) (0)
- Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis. (2023) (0)
- [Treatment of varices]. (1996) (0)
- [Choice of antibiotics in diarrhea due to Clostridium difficile]. (1999) (0)
- Nurse-driven post-discharge intervention reduces risk of readmission and non-attendance in patients with decompensated liver cirrhosis: a randomized controlled study (2022) (0)
- [Portal hypertension]. (1996) (0)
- Red blood cell sodium transport in patients with cirrhosis (2016) (0)
- [Cirrhotic cardiomyopathy: increased circulating pro-brain natriuretic peptide and brain natriuretic peptide in cirrhosis]. (2004) (0)
- Octreotide in cirrhotic patients (1998) (0)
- Adult Non-alcoholic Fatty Liver Disease (NAFLD) (2018) (0)
- Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study (2022) (0)
- [Violence against women in their partnerships. IV. Pattern of contact with public institutions]. (1985) (0)
- P1102 : No histological features of alcohol induced steatohepatitis can identify patients at risk of cirrhosis and premature death (2015) (0)
- The effect of terlipressin on blood volume distribution in patients with cirrhosis (2002) (0)
- Hemodynamic and humoral effects of posture in patients with cirrhosis and in controls (2003) (0)
- P516 Pro-C5: A NOVEL SEROLOGICAL MARKER OF TRUE TYPE V COLLAGEN FORMATION DETECTS PORTAL HYPERTENSION IN CIRRHOSIS (2014) (0)
- Patients with alcoholic-related cirrhosis have high burden of coronary arteriosclerosis compared to non-alcohol-related cirrhosis (2017) (0)
- Pitfalls in the assessment of intrapulmonary shunt using lung perfusion scintigraphy in patients with cirrhosis: authors' reply (2011) (0)
- Letter to the editorReply from the authors (1989) (0)
- DOP003 Proximal disease extension in patients with limited ulcerative colitis: a Danish population-based inception cohort. (2017) (0)
- 188 Reduced baroreceptor reflex sensitivity in cirrhosis. Relations to central haemodynamics and humoral systems (2006) (0)
- Failure to Control Bleeding and Failure to Control Rebleeding (2010) (0)
- Plasma Cystatin C is a predictor of renal failure, hepatorenal syndrome, ACLF and mortality in patients with acutely decompensated liver cirrhosis (2016) (0)
- OP19 Disease course and treatment outcomes of early resected Crohn’s Disease patients: A Danish nationwide cohort study from 1997 to 2015 (2021) (0)
- 801 - Liver Cirrhosis and Wound Healing: Activation of Von Willebrand Factor and Platelets (2018) (0)
- Liver cirrhosis and wound healing: Activation of von Willebrand factor and platelets (2018) (0)
- 584 ASSOCIATIONS BETWEEN BAROREFLEX SENSITIVITY, CARDIOVASCULAR REGULATION AND CENTRAL HYPOVOLAEMIA IN CIRRHOSIS AND PORTAL HYPERTENSION (2012) (0)
- Renal and circulatory effects of terlipressin in patients with hepatorenal syndrome assessed by magnetic resonance imaging (2022) (0)
- 751 THE ARTERIAL PRESSURE PROFILE IN PATIENTS WITH CIRRHOSIS. FOURIER ANALYSIS IN RELATION TO PRESSURE LEVEL, STROKE VOLUME, AND SEVERITY OF DISEASE (2009) (0)
- [Surgical treatment of diabetes mellitus type 2]. (2009) (0)
- P261 Systematic review with meta-analysis: The impact of concomitant immune-mediated diseases on the disease course of inflammatory bowel disease (2020) (0)
- P769 In Crohn's disease, an aggressive disease course is related to an increased abundancy of proteobacteria: a seven year follow up study. (2017) (0)
- SAT-138-Cirrhotic cardiomyopathy: A 2-year longitudinal follow-up study using advanced cardiac imaging (2019) (0)
- 582 Histology and prognosis in fatty liver patients (2004) (0)
- Hepatorenalt syndrom: diagnose, behandling og forebyggelse: diagnosis, treatment and prevention (2013) (0)
- [Adverse effects should be reported]. (2001) (0)
- S1962 Effects of Terlipressin On the Aquaretic System - Evidence of Antidiuretic Effects (2008) (0)
- [Cochrane review about the effect of acamprosate]. (2010) (0)
- 252 EFFECTS OF TERLIPRESSIN ON THE AQUARETIC SYSTEM. EVIDENCE OF ANTIDIURETIC EFFECTS (2008) (0)
- 610 PROGNOSTIC POTENTIAL OF CARDIAC AND PROINFLAMMATORY MARKERS IN CIRRHOSIS (2013) (0)
- [Etiology of acute and chronic pancreatitis over time at a hospital in Copenhagen]. (2010) (0)
- [Prognosis in hepatic steatosis]. (1997) (0)
- TREATMENT OF HEPATIC ENCEPHALOPATHY : TARGETING THE GUT-LIVER-BRAIN AXIS Summary of Presentations from the Norgine Sponsored Satellite Symposium , UEG Week , Berlin , Germany , 12 th – 16 th October 2013 (2013) (0)
- Disease Activity Patterns of Inflammatory Bowel Disease - A Danish Nationwide Cohort Study 1995-2018. (2022) (0)
- An unusual case of chylous ascites: A case report (2014) (0)
- 177 SPLANCHNIC DETERMINANTS OF THE HYPERDYNAMIC CIRCULATION AND CENTRAL HYPOVOLAEMIA IN CIRRHOSIS (2010) (0)
- Arterial compliance in cirrhosis. Relation to pathophysiology andeffect of vasoconstriction (2000) (0)
- Effects of chronic octreotide treatment on renal function in cirrhotic patients: a randomised, double-blind, controlled trial (2001) (0)
- 225 THE PROTEIN FINGERPRINT TECHNOLOGY REFLECTS LIVER FUNCTION AND DETECTS CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS (2013) (0)
- P421 Treatment optimization with vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn’s disease – a real-world two-center cohort study (2021) (0)
- 572 CARDIAC FUNCTION AND DYNAMICS OF QT INTERVAL IN PATIENTS WITH MILD CIRRHOSIS DURING MAXIMAL BETA-ADRENERGIC DRIVE: A DOBUTAMIN STRESS STUDY (2012) (0)
- pegylated interferon plus ribavirin in patients with chronic hepatitis C: A prospective randomized pilot study (2012) (0)
- Effect of paracetamol poisoning on international normalised ratio (2003) (0)
- Aquaporin-2 in Cirrhosis: Relation to Disease Severity, Markers of Renal Function and Impact on Development of Renal Insufficiency and Mortality (2016) (0)
- Biomarkers reflecting pericellular fibrosis improve together with liver histology after bariatric surgery in early non-alcoholic fatty liver disease. (2022) (0)
- 90 EVIDENCE OF A VASOPRESSIN-INDEPENDENT AQP2 EXPRESSION AND WATER RETENTION IN REFRACTORY ASCITES (2008) (0)
- 206 RIFAXIMIN IN THE TREATMENT AND PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN CHRONIC LIVER DISEASE: A META-ANALYSIS (2013) (0)
- [The diuretic profiles of Lasix and Ladix Retard. A comparative clinical study]. (1982) (0)
- Haemodynamic and humoral effects of posture in patients with cirrhosis and controls (2003) (0)
- [238] PULMONARY FUNCTION IN CIRRHOSIS: LOW PREVALENCE OF THE HEPATOPULMONARY SYNDROME (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Flemming Bendtsen?
Flemming Bendtsen is affiliated with the following schools: